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Abstract 
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder diagnosed by anovulation hyperandro-
genism. Hyperandrogenism increases apoptosis, which will eventually disturb follicular growth in PCOS patients. 
Since mitochondria regulate apoptosis, they might be affected by high incidence of follicular atresia. This may cause 
infertility. Since vitamin D3 has been shown to improve the PCOS symptoms, the aim of study was to investigate the 
effects vitamin D3 on mtDNA copy number, mitochondrial biogenesis, and membrane integrity of granulosa cells in 
a PCOS-induced mouse model.
Materials and Methods: In this experimental study, the PCOS mouse model was induced by dehydroepiandrosterone 
(DHEA). Granulosa cells after identification by follicle-stimulating hormone receptor (FSHR) were cultured in three 
groups: 1. granulosa cells treated with vitamin D3 (100 nM for 24 hours), 2. granulosa cells without any treatments, 
3. Non-PCOS granulosa cells (control group). Mitochondrial biogenesis gene (TFAM) expression was compared 
between different groups using real-time PCR. mtDNA copy number was also investigated by qPCR. The mitochon-
drial structure was evaluated by transmission electron microscopy (TEM). Hormonal levels were measured by an 
enzymelinked immunosorbent assay (ELISA) kit.
Results: The numbers of pre-antral and antral follicles increased in PCOS group in comparison with the non-PCOS 
group. Mitochondrial biogenesis genes were downregulated in granulosa cells of PCOS mice when compared to the 
non-PCOS granulosa cells. However, treatment with vitamin D3 increased mtDNA expression levels of these genes 
compared to PCOS granulosa cells with no treatments. Most of the mitochondria in the PCOS group were spherical 
with almost no cristae. Our results showed that in the PCOS group treated with vitamin D3, the mtDNA copy number 
increased significantly in comparison to PCOS granulosa cells with no treatments.
Conclusion: According to this study, we can conclude, vitamin D3 improves mitochondrial biogenesis and membrane 
integrity, mtDNA copy number in granulosa cells of PCOS mice which might improve follicular development and 
subsequently oocyte quality.
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Introduction 
Polycystic ovary syndrome (PCOS) is a common en-
docrine disorder in women (1). Menstrual dysfunction, 
anovulation, hyperandrogenism, hirsutism, and polycys-
tic ovaries are considered as the symptoms of PCOS (2). 
Hyperandrogenism stimulates follicular atresia in granu-
losa cells via apoptosis. As a result, apoptosis and oxida-
tive stress can interfere with follicular growth in women 
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suffering from PCOS (3). Therefore, disruption of folli-
cular growth in patients suffering from PCOS is related 
to granulosa cells apoptosis and oxidative stress caused 
by high production of reactive oxygen species (ROS). 
Since mitochondria can regulate apoptosis and ROS pro-
duction, these organelles may be affected by high rates 
of follicular atresia in the PCOS patients (4). Changes in 
the mitochondrial function might cause insulin resistance, 
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oxidative stress, hyperandrogenism, and glucose intoler-
ance, leading to the appearance of PCOS symptoms (5-7). 
The disturbance of mitochondrial function in granulosa 
cells may cause some disorders in oocyte function, matu-
ration, and fertilization. This may also affect the fertility 
of PCOS patients by reducing the oocyte quality. There-
fore, the proper functionality of mitochondria is of im-
portance in this regard (5). Mitochondria play a key role 
in the determination of numerous factors involved in the 
reproduction, such as oocyte quality, follicular growth, 
development, and granulosa cell proliferation (6). Mito-
chondria also mediate various cellular processes, includ-
ing apoptosis, ROS production, calcium signaling, adeno-
sine triphosphate (ATP) synthesis, pyrimidine synthesis, 
and Fe-S protein synthesis (3, 8). Furthermore, mitochon-
dria, as the main organelle for cellular ROS production, 
can also impair mitochondrial DNA (mtDNA), which may 
subsequently be the cause of different diseases. Being 
more susceptible to oxidative damage and attaining high 
rates of mutations are more common in the mitochondrial 
genome than nuclear DNA due to the adjacency to the 
electron transport chain (ETC), lack of sheltering histones 
and inefficient DNA repair capabilities (9). mtDNA of 
mammals is nearly 16 kb in size, encrypting 13 proteins of 
the oxidative phosphorylation (OXPHOS) complexes, 22 
ribosomal RNAs (rRNA), and transfer RNAs (tRNA) that 
are required for mitochondrial mRNA translation. mtD-
NA, like nuclear DNA, can influence mitochondrial gene 
expression, biogenesis, and function through epigenetic 
modifications (10). It is of note to mention that mitochon-
drial biogenesis can also influence mtDNA and nuclear-
encoded protein synthesis, the congregation of the double 
genetic origin derived proteins, mtDNA replication as well 
as cell growth and proliferation (11). Mitochondrial bio-
genesis is hard to understand and needs several processes, 
such as synthesis of mtDNA and nuclear genes (12). The 
main gene in mitochondrial biogenesis that is critical for 
mtDNA transcription and maintenance is mitochondrial 
transcription factor A (TFAM). Mitochondrial biogenesis 
is also regulated by nuclear genes such as NRF2, which 
controls the other factors in mitochondria (11).
Since oocyte quality is a crucial factor for conception in 
PCOS patients and that depends on mitochondrial func-
tion and structure, prescription of an appropriate medica-
tion may improve fertility rate as a consequence of im-
proved oocyte quality (13). Different treatments have been 
trialed, and vitamin D3 is one of which to have shown 
signs of improvement in PCOS patients (6). Vitamin D3 
has been used before to alleviate signs of insulin resist-
ance, hyperandrogenism, and oxidative stress in PCOS 
patients and other metabolic disorders (14). Vitamin D3 
also has an important role in calcium homeostasis, cel-
lular proliferation, and differentiation(15). Recently it has 
been demonstrated that the low level of vitamin D can 
result in excessive androgen secretion, insulin resistance, 
and follicular growth interruption in the patients suffer-
ing from PCOS. These occur through the decline of sex 
hormone-binding globulin (SHBG) levels, insulin recep-
tors, and calcium dysregulation (8). The serum concentra-
tion of 25-hydroxyvitamin D in women with PCOS is less 
than 20 ng/ml, which can exacerbate PCOS symptoms 
(16). Therefore, in this study, we aimed to investigate the 
effects of vitamin D3 on the mitochondrial biogenesis, 
membrane integrity, and mtDNA copy numbers in the 
granulosa cells isolated from PCOS-induced mice.
Materials and Methods
PCOS animal model and assessment of morphology
This is an experimental study that the effect of vitamin 
D3 on mitochondrial biogenesis in a PCOS mouse model 
was investigated. Androgen excess and other symptoms 
of PCOS were induced by the injection of DHEA (Sigma, 
Austria), 6 mg/100 g body weight. DHEA was dissolved 
in 95% ethanol (0.01 mL) and mixed with sesame oil (0.09 
mL). Subsequently, it was injected subcutaneously into 
female BALB/C mice (25 days old) for 20 consecutive 
days before reaching puberty (PCOS group, n=20). As a 
vehicle control, 0.1 mL of sesame oil (Sigma, Austria) and 
0.01 mL of 95% ethanol (Sigma, Austria) were injected 
into another group of the same mouse strain for 20 con-
secutive days (n=20). A Control group of the same mouse 
strain without any treatment was also considered (n=20). 
The mice were kept at room temperature (25 ± 1°C, RT), 
with enough food and water, and under diurnal modula-
tion by daily light. All the animal trials were performed 
in agreement with the Institutional Animal Care Com-
mittee of Iran University of Medical Sciences and Health 
Services for animal welfare. (ethics code: IR.IUMS.REC 
1396.29969). The weight changes in mice were measured 
every day. Vaginal smears were also taken every day over 
the 20-day course of treatment. The mice were sacrificed 
by cervical dislocation. For histological assessments, the 
ovaries were subsequently fixed with 10% formalin (Mer-
ck, Germany). Next, 5-μm sections were made with a mi-
crotome, and the sections were immersed in xylene and 
ethanol with different grades for deparaffinization and 
rehydration, respectively (Merck, Germany). The ovaries 
were then stained with hematoxylin and eosin (DAKO, 
USA). For morphology assessment, the ovaries assessed 
by a Nikon microscope (Nikon, Japan), and photographs 
were taken.
Sex hormones assessments
For the analysis of sex hormones, cardiac blood 
samples were collected using needles. Blood serum 
was subsequently separated using a centrifuge machine 
at (300 rpm, 4°C, 10 minutes) and follicle-stimulating 
hormone (FSH), luteinizing hormone (LH), 17β-estradiol 
(E2) and progesterone levels were measured by an 
ELISA kit (Abcam, Cambridge, UK) according to the 
manufacturer's guidelines.
Isolation and culture of granulosa cells
The ovaries of 45-day BALB/C mice (DHEA-reated 
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and the vehicle group) were removed after the mice were 
sacrificed via cervical dislocation. For aspiration of the 
follicles, 25-gauge needles were used, and the follicles 
were aspirated in a solution made of phosphate buffer sa-
line (PBS) and 1.0% bovine serum albumin (BSA) (In-
vitrogen, USA). 70-μm cell strainers (BD Falcon, MA, 
USA) were used to isolate granulosa cells from the other 
cells and tissues. Subsequently, granulosa cells were sep-
arated from the oocytes with a 40-μm cell strainer (BD 
Falcon, MA, USA). Blood cell contamination was re-
moved by RBC lysis buffer after centrifugation at 1000 
rpm (4°C, 10 minutes). Then, the pellet was mixed with 
phenol red-free DMEM/F12 medium containing 10% fe-
tal bovine serum (Sigma, Austria). The medium was cen-
trifuged at 1000 rpm (4°C, 10 minutes). Next, the pellet 
was removed and transferred to cell culture dishes con-
taining DMEM-F12, 10% FBS (Sigma, Austria), 100 mg/
mL streptomycin (Sigma, Austria), 100 IU/mL penicillin 
(Sigma, Austria), 2 mM glutamine (Sigma, Austria), 1 
mM sodium pyruvate (Sigma, Austria). The culture dish-
es were then incubated at 37°C, with 5% CO2 and 95% 
humidity.
Identification of isolated GCs
To identify granulosa cells, an antibody against FSHR, 
a specific marker of granulosa cells, was used. Affinity-
purified rabbit anti-follicle stimulating hormone recep-
tor (FSHR) polyclonal antibody was purchased from 
antibodies-online (ABIN1872743). First, the cells were 
spread on a slide using a cytospin centrifugation device, 
and the slides were then immersed in a cold normal buff-
ered formalin (NBF) solution to be fixed. Subsequently, 
the cells were washed with PBS and blocked using PBS-
Triton/BSA. Afterward, the primary FSHR antibody was 
added to granulosa cells overnight. The following morn-
ing the cells were washed three times with PBS and were 
subsequently treated with the secondary FSHR antibody 
for 30 minutes. DNA was counterstained with 4′,6-diami-
dino-2-phenylindole (DAPI). Preparations were washed 
in PBS before mounting on glass slides. Slides were 
viewed on an epifluorescence microscope and captured 
with a digital camera. 
Experiment design
The treatment groups for granulosa cells were as fol-
lows:
1. PCOS granulosa cells treated with vitamin D3 (100 
nM) for 24 hours (17, 18)
2. PCOS granulosa cells without any treatments 
3. Non-PCOS granulosa cells (control group) 
Reverse transcription- polymerase chain reaction and 
quantitative reverse transcription- polymerase chain 
reaction 
The Trizol reagent (Sigma, Austria) was used to extract 
the total RNA of granulosa cells in all groups. Then, chlo-
roform was added to the mixture of granulosa cells and the 
Trizol reagent. Afterward, the mixture was centrifugated 
at 1000 rpm (4 C, 10 minutes). The upper phase contain-
ing the total RNA was collected. Next, the total RNA was 
washed with 75% ethanol, allowed to air dry, and then re-
constituted in diethylpyrocarbonate (DEPC) water. Using 
a cDNA synthesis kit (Thermo Scientific, USA), the total 
RNA was reverse-transcribed according to the manufac-
turer’s guideline. In summary, a mixture of the random 
hexamer, first-strand buffer (all from Fermentas), DNase-
(Fermentas Inc, MD, USA) treated RNA, RiboLockTM 
RNase inhibitor, dNTP Mix, Dithiothreitol (0.1M) and 
SuperScriptTM II Reverse Transcriptase was made for 
reverse transcription of each sample. The thermocycler 
(company) was set at 25°C for 10 minutes, 43°C for 40 
minutes, and 75°C for 15 minutes. Quantitative PCR was 
performed using 1 μl of cDNA in a reaction consisting of 
ROXTM Reference Dye, SYBR Premix EX TaqTM (Ta-
kara, Japan), and 1 μl of the desired primer. The β-actin 
gene was utilized as a housekeeping gene. The reactions 
were amplified with StepOne™ Real- Time PCR System 
(Applied Biosystems, MA, USA) as following: denatura-
tion at 95 °C for 10 seconds, 35 cycles of amplification 
(95°C for 5 seconds and 60°C for 30 seconds), separation 
stage at 95°C for 15 seconds, 60°C for 1 minutes, and 
95°C for 15 seconds. Using oligo 7.60 software to design 
primers. The TFAM forward primer was CCG AGC TCC 
TCC TCC TTT GC and the TFAM reverse primer was 
CCT ACA ACG CAG CGA CCG AG.
Mitochondrial DNA quantification
For the measurement of the mtDNA copy number, quan-
titative polymerase-chain-reaction (qRT-PCR) was used. 
Forward primer and reverse primer were used to analyze 
mtDNA. SYBR Green I Master Mix (10 μl) (Sigma, Aus-
tria), which contains 10 pmol of reverse primer and 10 
pmol of forward primer was mixed with DNA (10 ng). 
The qPCR set-up consisted of 4 segments: 50°C for 2 
minutes, 95°C for 10 seconds followed by 40 cycles of 
denaturation at 95°C for 5 seconds, annealing at 59°C 
for 35 seconds, and extension at 72°C for 1 minutes. For 
each qPCR reaction, the copy number of the mtDNA and 
the threshold cycle number (Ct) of the β-actin gene were 
measured. The runs were replicated at least two times, and 
the normalization was performed against the housekeep-
ing gene, β-actin. For the quantification of the mtDNA 
copy number, the double delta Ct analysis was applied.
Electron microscopy of mitochondria
Isolated granulosa cells were fixed using 2.5% glutar-
aldehyde in PBS and then treated with 1.0% osmium te-
troxide in the same buffer for the post-fixation procedure. 
For performing the dehydration process, ethanol and pro-
pylene oxide were used. Then inserted in epoxy resin, and 
sectioned. Using ethanolic uranyl acetate to contrast the 
sections and lead citrate and observed under a transmis-
sion electron microscope (Zeiss LEO 906 (TEM), 100 kV, 
Germany).
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Statistical analysis
The data in this experiment are expressed as the means 
and standard error of the mean (19) for three independ-
ent biological replicates. Statistical significance between 
different groups was evaluated and analyzed by on-way 
analysis of variance (ANOVA), followed by Tukey’s post 
hoc test. The level of statistical significance was set at 
P<0.05. The SPSS software (version 21.0) was utilized 
for the data analysis.
Results
Hormonal levels and cycle alteration in mice
In the PCOS group induced by DHEA, the serum level 
of estradiol and LH were higher when compared to con-
trol and vehicle groups, respectively (Table 1). The lower 
amount of FSH serum was detected in the PCOS group 
versus the control group and vehicle group due to estra-
diol negative feedback. The ratio of LH/FSH was signifi-
cantly increased in the PCOS group in comparison to the 
vehicle group (Table 1). The estrous cycle was irregular in 
the PCOS group and ultimately stopped, whereas, in the 
control and vehicle group, normal cycles (nearly 5-7 days) 
continued as normal. Using mice in the control and vehicle 
groups that were just in the estrous cycle to exclude the 
influence of the estrous cycles on other measurements.
Table 1: Hormonal levels
Hormone Control Vehicle DHEA
Estradiol (pg/mL) 132 ± 9.10 142 ± 8.52 3786 ± 13.1**
FSH (IU/L) 6. 59 ± 0.82 6.84 ± 0.29 4.11 ± 0.64
LH (IU/L) 5.60 ± 0.11 6.13 ± 0.38 18.58 ± 0.82*
LH/FSH (IU/L) 0.84 ± 0.13 0.89 ± 1.31 4.52 ± 1.28**
Progesterone (pg/mL) 3.647 ± 0.69 3.268 ± 0.54 2.369 ± 0.19 
Data are presented as mean ± SD. *; P<0.05, **; P<0.005, FSH; Follicle-stimulating 
hormone, LH; Luteinizing hormone, DHEA; dehydroepiandrosterone.
Histological analysis for characterization of PCOS 
ovaries
Upon H&E staining, the specimen was analyzed under 
the light microscope. Normal follicles were detected at 
various developmental stages in the vehicle group. Cor-
pus luteum was also observed in the control group, which 
was an indicator of normal ovulation (Fig.1A). Due to the 
seizure of the estrus cycle, no corpus luteum was detected 
in the PCOS group (Fig.1B).
Fig. 1: Histological assessment of ovaries. A. Follicles of normal ovaries 
represented follicles at different stages, and corpus luteum (CL) and B. 
Ovaries of the polycystic ovary syndrome (PCOS) model induced by de-
hydroepiandrosterone (DHEA) revealed antral and pre-antral follicles and 
some cysts (FC) were observed in H&E staining. No corpus luteum was 
observed in the PCOS ovary .Scale bar: 50 μm. 
Mitochondrial biogenesis gene expression
To assure that the cells being experimented on granu-
losa cells, a granulosa cell antibody was used against 
FSHR. Photograph analysis showed that the target cells 
were stained with this antibody, indicating that they were 
granulosa cells (Fig.2). Thus, for the treatment of granu-
losa cells, vitamin D3 (100 nM) was used for 24 hours. 
Subsequently, RNA was extracted, and Reverse transcrip-
tion- polymerase chain reaction (RT-PCR) performed to 
measure the expression of mitochondrial biogenesis gene 
(TFAM) in different groups. Vitamin D3 increased the ex-
pression of TFAM in the PCOS group (Fig.3) by 5-fold 
compared to the PCOS group without any vitamin D3 
treatment. This indicates that vitamin D3 might stimulate 
mitochondrial biogenesis in PCOS-induced granulosa 
cells.
Fig. 2: Follicle-stimulating hormone receptor (FSHR) (specific markers of granulosa cells) was investigated. The FSHR expression in isolated granulosa cells 
(green) was observed. Nuclei (blue) were stained by 4′,6-diamidino-2-phenylindole (DAPI). Scale bar: 100 μm.
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Fig. 3: The expression of TFAM (mitochondrial biogenesis gene) in cultured 
granulosa cells of DHEA-induced PCOS BALB/C mice was compared between 
three groups. Granulosa cells were pre-incubated in the serumfree medium in 
the presence or absence of vitamin D3. The expression of the mitochondrial 
biogenesis gene was upregulated in the vitamin D3 group. It is also revealed 
that the gene expression was declined in PCOS granulosa cells in comparison 
with non-PCOS healthy granulosa cells (control group), ***; P<0.05, DHEA; De-
hydroepiandrosterone, and PCOS; Polycystic ovary syndrome.
Mitochondrial DNA
For the analysis of the mtDNA, qPCR was performed. 
Our results revealed that in the PCOS group treated with 
vitamin D3, the mtDNA copy number increased sig-
nificantly in comparison to the non-treated PCOS group 
(Fig.4). Data analysis by the quartile distribution of mtDNA 
copy number in the non-treated PCOS group showed an 
association between mtDNA copy number and PCOS risk. 
Fig. 4: The mitochondrial DNA copy number (mtDNA) in cultured granu-
losa cells of DHEA-induced PCOS BALB/C mice was compared between 
three groups. Granulosa cells were pre-incubated in the serum-free me-
dium in the presence or absence of vitamin D3. The mitochondrial DNA 
copy number was significantly increased in the vitamin D3 group in com-
parison with the non-treated PCOS group (**; P<0.05). It is also revealed 
that the mitochondrial DNA copy number was declined in the non-treated 
PCOS granulosa cells in comparison with the non-PCOS healthy granulosa 
cells (control group). DHEA; Dehydroepiandrosterone, PCOS; Polycystic 
ovary syndrome.
Transmission electron microscopy of mitochondria 
structure
For the evaluation of the alterations of the mitochon-
dria structure, transmission electron microscopy was 
employed. Most of the mitochondria in the PCOS group 
without any treatment were spherical, with almost no cris-
tae; however, in the PCOS group treated with vitamin D3 
as well as in the non- PCOS group (control group) in-
tact inner and outer membrane and a clear intermembrane 
space was observed (Fig.5).
A
B
Fig. 5: Mitochondria membrane structure (TEM). A. PCOS group without 
any treatments were spherical with almost no cristae (arrow: abnor-
mal mitochondria). B. PCOS group treated with vitamin D3 and also in 
the non-PCOS group (control group) include undamaged mitochondria 
(arrow: normal mitochondria).
Discussion
The present study demonstrated that vitamin D3 af-
fected mtDNA copy number, mitochondrial structure, and 
mitochondrial biogenesis in granulosa cells of a PCOS-
induced mouse model in comparison with healthy normal 
ovaries. PCOS is regularly described by oligomenorrhea, 
chronic anovulation, hyperandrogenism, and hyperinsu-
linemia (20). Androgenic hormones, such as DHEA, tes-
tosterone, and androstenedione, cause some problems in 
the patients suffering from PCOS (2). According to pre-
vious studies, in the PCOS ovaries, the atretic follicles 
increased that caused by hyperandrogenism, which is 
critical in the pathogenesis of PCOS. High levels of an-
drogen in women that suffer from PCOS might intensify 
follicular atresia and follicular development disruption 
that might cause subfertility (4). According to our previ-
ous study (17), to mimic the hyperandrogenism condition, 
for induction of the PCOS model and also confirmation of 
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the abnormal hormonal level and ovarian morphological 
features in PCOS mice, DHEA was injected into the 25-
day old female mice intraperitoneally. Androgen excess, 
insulin resistance, and disturbed follicular development 
are some symptoms of this disorder that might interfere 
with female fertility (21-23). The levels of LH, estradiol, 
along with the ratio of LH to FSH were increased in the 
PCOS-induced mice compared to the vehicle group. The 
level of FSH was comparatively decreased in the PCOS 
group caused by the estradiol level feedback.
Disrupted ovulation and oocyte quality induced by hy-
perandrogenism can be improved by different treatments 
such as metformin and spironolactone (7). Besides hor-
monal treatments, various supplements such as vitamin 
D3 have been shown to improve the PCOS symptoms 
(24). Moreover, several lines of evidence demonstrate 
the positive role of vitamin D3 in some disorders, such as 
premature ovarian failure (POF), endometriosis, PCOS, 
and male infertility (17, 25). It has been demonstrated that 
vitamin D3 might stimulate follicular development in pa-
tients with PCOS; however, it could not alleviate disrupt-
ed lipid and glucose metabolism (26-28). A large body of 
studies has shown that vitamin D3 has constructive ef-
fects on alleviating the symptoms of ovulation disorders 
and insulin resistance in women suffering from PCOS 
disorder (17, 29). Hormonal fluctuations in PCOS women 
can be improved by vitamin D3; however, the duration of 
treatment can influence the degree of symptom alleviation 
(14, 26). Underlying mechanisms as to how vitamin D3 
exerts its effects are yet to be elucidated.
For the assessment of the effect of vitamin D3 on mito-
chondrial biogenesis, isolated granulosa cells from PCOS 
ovaries were treated with vitamin D3. Mitochondrial mem-
brane integrity and alteration in mtDNA copy numbers were 
also evaluated. It has been demonstrated that mitochondria, 
as the powerhouse of the cell, are of importance for opti-
mum oocyte quality and fertilization. Poor oocyte quality 
and subsequent embryonic development could be attribut-
ed to mitochondrial dysfunction (10, 15). We hypothesized 
that vitamin D3 may improve mtDNA copy number, mito-
chondrial membrane integrity, and biogenesis.
In the present study, we demonstrated that mitochondri-
al biogenesis could be upregulated after 24 hours of treat-
ment with vitamin D3. The findings showed that vitamin 
D3, as a supplementation, improves the main mitochon-
drial biogenesis marker (TFAM) in the granulosa cells of 
PCOS ovaries. According to some evidence, TFAM plays 
an important role in mitochondrial biogenesis (12, 30-33). 
It is revealed that total antioxidant capacity (TAC) raise 
by vitamin D3 and also vitamin D3 may alleviate the hor-
monal disturbances in women with PCOS (34, 35). Since 
our results showed that vitamin D3 has an improvement 
effect on ovulation problems and follicular disruption, we 
could understand that vitamin D3 might have an impor-
tant role in declining the atretic follicles and alleviating 
the development of follicles via upregulating the mito-
chondrial biogenesis main gene and mitochondrial mem-
brane integrity.
In this study, for the first time, we have shown the vita-
min D3 effect on mtDNA copy number and mitochondrial 
membrane integrity in a mouse model of PCOS granulosa 
cells. Our results revealed that most of the mitochondria 
in the PCOS group were spherical with almost no cristae. 
In line with our study, Longfei et al. revealed a distorted 
mitochondrial structure and diminished membrane integ-
rity in the PCOS group (10). Oocytes of the PCOS mouse 
model, induced with DHEA, have demonstrated disrupted 
mitochondrial biogenesis, decreased mtDNA copy num-
ber, and distorted mitochondrial ultrastructure that is in 
agreement with our findings in this study (10, 36). Ding 
et al. also observed that mitochondrial dysfunction, due 
to mtDNA mutation, has a role in the manifestation of 
PCOS symptoms that is in line with our results (37). Re-
duced mtDNA copy number is associated with poor oo-
cyte quality and subsequent compromised embryo devel-
opment and implantation (10) (15). Our findings showed 
decreased mtDNA copy number in the PCOS group (non-
treated), which is increased upon treatment with vitamin 
D3.
In line with this finding, researchers showed reduced 
mtDNA copy number in the PCOS patients (37, 38). 
Also, in agreement with our findings, a case-control study 
showed reduced mtDNA copy number in Korean women 
suffering from PCOS (9, 10, 39). Bhanoori et al. (9) also 
demonstrated that mtDNA copy number severely de-
creased in PCOS patients.
Conclusion
According to our results, mtDNA copy number, the 
biogenesis might be affected by vitamin D3 in PCOS 
granulosa cells. We nominate that mitochondrial bio-
genesis genes expression might be increased by vitamin 
D3. Therefore, vitamin D3 can have a significant role in 
the alleviation of mitochondria and follicular damages in 
PCOS ovaries. However, extensive studies are needed to 
determine the optimal dose and duration of treatment with 
vitamin D3 in PCOS women.
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